All News

When breast cancer patients are misclassified by subtype, it can mean the best treatment options are delayed.

Hormonal maintenance therapy may be able to improve PFS rates for some patients with ovarian cancer, according to a recent study.

Neoadjuvant treatment may decrease the amount of surgery some women with breast cancer need to have, says Debu Tripathy, M.D.

A recent study found that a person's diet, particularly the amount of antioxidants they eat, can have an impact on lung cancer risk.

You readily see the physical changes caused by cancer, but what goes on in your mind is just as noteworthy.

There are times when talking to another cancer patient, someone just like you, could be the key to better coping and a better life with this disease. Join a conversation, make a call, go online to make a positive change.

James Brugarolas, M.D., Ph.D., discusses the importance of spotting the difference between a metastatic kidney cancer lesion and a separate lung cancer. The difference can save patients' lives.

Receiving a diagnosis of NED (no evidence of disease) is reason for celebration!

Breast cancer and melanoma survivor says you are allowed to feel what you are feeling, whatever that is.

Keytruda (pembrolizumab) was approved for the treatment of refractory or relapsed Hodgkin lymphoma.

Immunotherapy has drastically shaped the treatment of lung cancer. Vassiliki A. Papadimitrakopoulou, M.D., looks forward to what's next.

New guidelines may result in a small percentage of patients with breast cancer being misclassified and not receiving proper treatment, Michael F. Press, M.D., Ph.D., says.

My chemo’d brain and five ways that help me remember not to forget.

Only in a family like mine, where breast cancer comes up fairly often, would my daughter Kirtley call me into the bathroom to see a pimple on her breast at age 14.

Kisqali (ribociclib), a CDK 4/6 inhibitor, gained approval from the Food and Drug Administration (FDA) for the frontline treatment of postmenopausal women with hormone-receptor (HR)–positive, HER2-negative advanced breast cancer.

Multiple trials are testing the potential of immunotherapy combinations in breast cancer. The results are exciting, explains Elizabeth A. Mittendorf, M.D., Ph.D.

I guess I’m old school when it comes to a cancer diagnosis. I have always assumed there are three types of cancer—the good (which is a diagnosis of “no cancer”), the bad and the ugly.

After surgery and treatment, some breast cancer survivors may develop fibromyalgia. Medication can help, but it's an individual choice to take it.

Teaching the patient and caregiver reportable signs and symptoms and when to call the doctor cannot only save their line, but, more importantly, can save their life.” — WENDY A. NUNEZ , R.N.

Leo I. Gordon, M.D., discusses an exciting new trial for patients with non-Hodgkin lymphoma.

Reflections of sharing our story over this past year

The supplemental biologics license application (sBLA) for Keytruda (pembrolizumab) is still under review by the Food and Drug Administration (FDA) to treat MSI-H cancer.

Since 2000, and the hundreds of new approaches to cancer treatment, a new kind of patient has emerged — one who may live years beyond their initial prognosis by moving from treatment to treatment.

Marcia Goglia was given a laxative in the ER for what turned out to be ovarian cancer.

Humor can be a valuable healing strategy for patients with cancer and their doctors.

Charles Drake, M.D., Ph.D.. is optimistic about immunotherapy as it continues to move toward the frontline setting in GU cancers.

A recent phase 3 study showed that Imbruvica plus ublituximab may be a promising option for some patients with CLL.

Stereotactic body radiation therapy (SBRT) is highly effective, and potentially curable for early-stage lung cancer, though not many physicians use the therapy, says expert Molly Freeman, C.N.P.

Winning (and losing) the Academy Awards can be like fighting cancer.

Sometimes a cat isn't your problem, it's actually lymphoma.